Bio Reference Laboratories Inc (BRLI) financial statements (2021 and earlier)

Company profile

Business Address 481 EDWARD H ROSS DR
ELMWOOD PARK, NJ 07407-3118
State of Incorp. NJ
Fiscal Year End October 31
SIC 8071 - Medical Laboratories (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

10/31/2014
10/31/2013
10/31/2012
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments181825
Cash and cash equivalents181825
Receivables263206153
Inventory, net of allowances, customer advances and progress billings211915
Inventory211915
Prepaid expense and other current assets95
Other current assets10 
Other undisclosed current assets404225
Total current assets:352295224
Noncurrent Assets
Property, plant and equipment666650
Long-term investments and receivables555
Long-term investments555
Intangible assets, net (including goodwill)505230
Goodwill353523
Intangible assets, net (excluding goodwill)14166
Deposits noncurrent assets111
Other noncurrent assets1 
Prepaid expense and other noncurrent assets11
Other undisclosed noncurrent assets(63)(64)(48)
Total noncurrent assets:616139
Other undisclosed assets666650
TOTAL ASSETS:479422313
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities10310068
Accounts payable716241
Employee-related liabilities162016
Taxes payable161810
Debt764
Other undisclosed current liabilities3529 
Total current liabilities:14513472
Noncurrent Liabilities
Long-term debt and lease obligation151414
Long-term debt, excluding current maturities344
Capital lease obligations12119
Other undisclosed noncurrent liabilities 2 
Total noncurrent liabilities:151614
Total liabilities:16015086
Stockholders' equity
Stockholders' equity attributable to parent319272227
Common stock000
Additional paid in capital403941
Retained earnings279232186
Total stockholders' equity:319272227
TOTAL LIABILITIES AND EQUITY:479422313

Income statement (P&L) ($ in millions)

10/31/2014
10/31/2013
10/31/2012
Revenues
(Revenue, Net)
832715662
Cost of revenue
(Cost of Goods and Services Sold)
(462)(393)(338)
Gross profit:370323324
Operating expenses(212)(224)(167)
Other undisclosed operating loss(75)(16)(80)
Operating income:838276
Nonoperating expense(3)(0)(2)
Investment income, nonoperating(0)1(0)
Other nonoperating expense(2)(1)(2)
Interest and debt expense(2)(2)(1)
Other undisclosed income from continuing operations before equity method investments, income taxes312
Income from continuing operations before equity method investments, income taxes:818175
Loss from equity method investments(0)(0)(0)
Income from continuing operations before income taxes:818174
Income tax expense(34)(35)(32)
Net income attributable to parent:474542
Other undisclosed net income available to common stockholders, basic000
Net income available to common stockholders, diluted:474642

Comprehensive Income ($ in millions)

10/31/2014
10/31/2013
10/31/2012
Net income:474542
Comprehensive income, net of tax, attributable to parent:474542

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: